Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.

Antiviral therapy - 1 Jan 2009

Reynolds Steven J, Kityo Cissy, Mbamanya Frank, Dewar Robin, Ssali Francis, Quinn Thomas C, Mugyenyi Peter, Dybul Mark

Abstract excerpt

BACKGROUND: This study aimed to determine the extent of viral resistance over time among non-clade B HIV type-1-infected patients in Uganda who were maintained on first-line highly active antiretroviral therapy (HAART) following virological failure. METHODS: Genotyping was performed on 16 patients with virological failure who were enrolled in an open-label randomized clinical trial of short-cycle treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzoxazines

Share to Cyclopropanes

Share to Lamivudine

Share to Thymidine

Share to Treatment Failure

Share to Uganda

Source

Open in PubMed Open full text

Identifiers

PMID: 19430104
DOI: 10.1177/135965350901400211
PMCID: PMC2749943

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.PMID 19430104Read ↗

High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.Semantic proximity Read ↗

HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.Semantic proximity Read ↗

Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Semantic proximity Read ↗

HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.Semantic proximity Read ↗

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.Semantic proximity Read ↗

Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.Semantic proximity Read ↗

Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Semantic proximity Read ↗

Resistance to antiretroviral therapy among patients in Uganda.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa.Semantic proximity Read ↗

Low drug resistance levels among drug-naive individuals with recent HIV type 1 infection in a rural clinical cohort in southwestern Uganda.Semantic proximity Read ↗

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.Semantic proximity Read ↗

High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.